BociMed
Shanghai BociMed Pharmaceutical Research Co., Ltd. (上海博志研新药物研究有限公司) is a Chinese pharmaceutical CRO/CDMO founded in 2012 in the Zhangjiang Pharmaceutical Valley, Shanghai, with an R&D headquarters in Zhangjiang, a production base in Lingang, and a clinical subsidiary in Chengdu. BociMed offers small-molecule chemistry, CMC and process development, a portfolio of drug delivery technology platforms (oral, injectable, nasal, pulmonary, transdermal, ocular, implant, liposome and exosome), clinical research and SMO services, global regulatory registration consulting, and commercial API, intermediate and solid-dosage manufacturing. It is a laboratory and manufacturing services business rather than a software vendor: it publishes a marketing website in Chinese and English and no developer program, public API, SDK or machine-readable specification of any kind.
BociMed is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Life Sciences, Contract Research Organization, and CDMO.
BociMed’s developer surface includes engineering blog, support, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 5
The organization behind the API
Other 1
Properties that don't map to a standard resource type